Scientists accelerate immune response to tuberculosis in mice

December 22, 2016
This photomicrograph reveals Mycobacterium tuberculosis bacteria using acid-fast Ziehl-Neelsen stain; Magnified 1000 X. The acid-fast stains depend on the ability of mycobacteria to retain dye when treated with mineral acid or an acid-alcohol solution such as the Ziehl-Neelsen, or the Kinyoun stains that are carbolfuchsin methods specific for M. tuberculosis. Credit: public domain

New research findings provide insight into the immune system pathways that may be key to developing an effective tuberculosis (TB) vaccine. The study, to be published Thursday in the journal Nature Communications, was supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

Globally, an estimated 10.4 million new TB cases occurred in 2015, according to the World Health Organization. A TB vaccine called bacille Calmette-Guérin (BCG) is currently used in countries with a high prevalence of TB to prevent severe forms of the disease in children. However, the protection provided against pulmonary TB in adults is very variable, and people vaccinated with BCG are more likely to give false positives on skin tests for TB.

Therefore, researchers are working to create an improved TB vaccine. In animal research, scientists have found that during an infection with the tuberculosis bacterium Mycobacterium tuberculosis, called T are slow to congregate in the lungs and attack the invaders, allowing for infection to develop despite vaccination.

Previous research has suggested that a key to a faster immune response might lie with dendritic cells that present molecules from bacteria, viruses, and other harmful invaders to disease-fighting T cells, prompting the T cells to attack incoming pathogens. In this new study, scientists led by a group at Washington University in St. Louis investigated whether the delay could be prevented by activating certain immune pathways. First, the researchers established that T cells from vaccinated mice were capable of responding well to TB bacteria. The scientists then introduced dendritic cells that had already been "primed" by exposure to molecules from TB bacteria into the lungs of vaccinated mice, and exposed the mice to different strains of M. tuberculosis. The researchers found that the vaccinated mice that also received activated dendritic cells at the time of infection reached near-sterilizing levels of immunity against TB.

Next, the scientists tried to activate the same immune pathways but without the primed dendritic cells. Specifically, mice vaccinated with the BCG vaccine were treated with two different experimental compounds (amph-CpG and FGK4.5) along with TB antigens designed to activate dendritic cells in the lungs, and then exposed to TB bacteria. The treated mice mounted faster and stronger immune responses against the bacteria, the researchers report.

The scientists note that the technique they used in mice may be impractical in humans because the compounds or activated would need to be applied at the time of infection, which is difficult to predict or detect in the real world. However, the research has led to a better understanding of the mechanisms of TB immunity, which may shape the direction of more effective TB vaccine research in the future, the authors wrote.

Explore further: Tuberculosis and HIV co-infection

More information: K. Griffiths et al. Targeting Dendritic Cells to accelerate T cell activation overcomes a bottleneck in tuberculosis vaccine efficacy. Nature Communications, (2016). DOI: 10.1038/NCOMMS13894

Related Stories

Tuberculosis and HIV co-infection

October 18, 2016

The HIV virus increases the potency of the tuberculosis bacterium (Mtb) by affecting a central function of the immune system. This is the conclusion of a study carried out by researchers at Linköping University in Sweden. ...

New cancer vaccine one step closer

June 2, 2016

A team led by Monash University and the University of Queensland has developed a new approach to harnessing the body's immune system to fight disease that could pave the way for a new class of cancer vaccine.

Immune cells that fight obesity

November 2, 2015

We tend to think of the immune system as guarding us against bacteria, viruses and assorted foreign invaders, but this system has some other surprising roles. Weizmann Institute researchers have now identified a small subtype ...

Recommended for you

When liver immune cells turn bad

April 21, 2017

A high-fat diet and obesity turn "hero" virus-fighting liver immune cells "rogue", leading to insulin resistance, a condition that often results in type 2 diabetes, according to research published today in Science Immunology.

Researchers unlock an immunity 'black box'

April 18, 2017

A research team led by St. Jude Children's Research Hospital immunologists has revealed a previously unknown immune machinery that goes awry to trigger the inflammatory disease neutrophilic dermatosis. Neutrophilic dermatoses ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.